Ibrahim M Ibrahim

8PUBLICATIONS
37CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 14, 2024
Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers.

Reda G Yousef, Ibrahim H Eissa, Hazem Elkady

|Dec 07, 2023
QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitors.

Abdelmoujoud Faris, Ibrahim M Ibrahim, Radwan Alnajjar

|Nov 13, 2023
Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3-d]pyrimidine.

Souad A El-Metwally, Hazem Elkady, Mohamed Hagras

|Oct 20, 2023
In silico computational drug discovery: a Monte Carlo approach for developing a novel JAK3 inhibitors.

Abdelmoujoud Faris, Ivana Cacciatore, Ibrahim M Ibrahim

|Aug 02, 2023
Discovery of new thieno[2,3-d]pyrimidines as EGFR tyrosine kinase inhibitors for cancer treatment.

Eman A Sobh, Mohammed A Dahab, Eslam B Elkaeed

|Jul 19, 2023
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations.

Hazem A Mahdy, Hazem Elkady, Mohammed S Taghour

Pageof 2

Frequent Collaborators

4 joint publications

Ibrahim H Eissa

3 joint publications

Ahmed M Metwaly

3 joint publications

Abdelmoujoud Faris

3 joint publications

Kamal Tabti